Trial Profile

A phase 1 trial of FH 2001 for the treatment of advanced malignant solid tumors

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 03 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs FH-2001 (Primary)
Indications Solid tumours
Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics; Therapeutic Use

Most Recent Events

03 May 2022 New trial record
13 Apr 2022 Status changed from planning to recruiting, as per results presented at the 113th Annual Meeting of the American Association for Cancer Research
13 Apr 2022 Trial design, presented at the 113th Annual Meeting of the American Association for Cancer Research

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com